Oncobiologics Inc is a clinical-stage biopharmaceutical company. It is engaged in identifying, developing, manufacturing and commercializing complex biosimilar therapeutics in the disease areas of immunology and oncology.
$2.20 +0.05 (2.09%)
As of 03/02/2021 15:59:11 EST IEX book CBOE book
2021 © Stock Market MBA, Inc.